Yuanqi Li1,2,3, Hao Huang1,2,3, Qi Wang1,2,3

  • 1Tumor Biological Diagnosis and Treatment Center, The Third Affiliated Hospital of Soochow University, Changzhou, China.

Frontiers in genetics
|June 11, 2024
PubMed
概括

在肝细胞癌 (HCC) 中透瘤的B淋巴细胞 (TIL-Bs) 呈现出不同的亚型,影响预后. 一种基于血细胞标记物的新型风险模型准确地预测了HCC患者的生存率和指导治疗选择.